The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms

BACKGROUND: Epigenetic control using histone deacetylase (HDAC) inhibitors is a promising therapy for lymphomas. Insights into the anti-proliferative effects of HDAC inhibitors on diffuse large B-cell lymphoma (DLBCL) and further understanding of the underlying mechanisms, which remain unclear to da...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ying, Cui, Wenli, Chen, Weixiang, Wei, Ping, Chi, Yayun, Zhang, Ping, Bi, Rui, Zhou, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681717/
https://www.ncbi.nlm.nih.gov/pubmed/23758695
http://dx.doi.org/10.1186/1475-2867-13-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681717/
https://www.ncbi.nlm.nih.gov/pubmed/23758695
http://dx.doi.org/10.1186/1475-2867-13-57

Ejemplares similares